Public Register's Annual Report Service - Free Corporate Annual Reports

Click to view Annual Reports available for immediate shipment

Annual Report Searches

Canadian Search

New Additions

Industry Search

Top 20 Most Requested

Alphabetical Search

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

We Do Not Ship To Addresses Outside North America

For international investors, please try our online service at http://www.publicregisteronline.com

INDICATOR MINERALS INC (IME:CDNX)

Add To Cart

RXI PHARMACEUTICALS CORPORATION (RXII:NASDAQ)

RXi Pharmaceuticals is a discovery-stage biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi) for the treatment of human diseases. RXi was founded by world-leading researchers in the field of RNAi, began operations in January of 2007 and started trading on the Nasdaq in March of 2008

FYE: 12/31	2009	2008	2007	2006
(in thousands, except per share amounts)
Net Income	(18,387)	(14,373)	0	0
Earnings Per Share	(1.24)	(1.09)	0.00	0.00

(in thousands, except per share amounts)
	First Quarter
FYE: 12/31	3/31/10	3/31/09
Net Interest Income	$0	$0
Non-Interest Income	0	0
Net Income	(3,886)	(4,171)
Earnings Per Share	(0.24)	(0.30)

Contact Name:	Donna Falcetti
Contact Title:	Investor Relations
Phone:	508-929-3615